Global private equity and venture capital news and research

Posts Tagged ‘cancer’

12 August 2014

Thiel’s Mithril Capital leads $15m round for cancer treatment company MagForce USA

MagForce Paypal co-founder Peter Thiel’s late-stage investment fund Mithril Capital has led a $15m financing round for nanomedicine-focused anti-cancer device maker MagForce USA.

7 August 2014

Venture capital-backed Juno Therapeutics raises $134m Series B

cancer juno Venture capital-backed biotechnology startup Juno Therapeutics has raised $134m in its Series B round to fund the development of its immunotherapies for cancer.

25 June 2014

Oncology focus pays off, says Nextech CEOp

alps For life sciences venture firms, it is riskier to have a broad focus than targeting a specific segment of the sector, according to Nextechinvest founding partner and CEO Alfred Scheidegger.

23 June 2014

Definiens raises €15m to expand into digital tissue diagnostics

analysis European venture capital firm Wellington Partners has led a €15m growth financing round for German digital pathology image analysis and digital tissue diagnostics specialist Definiens.

21 May 2014

Venture capital-backed Kite Pharma files for IPO

cancer band pink_sq Venture capital-backed biopharmaceutical startup Kite Pharma has filed for an IPO.

12 May 2014

Mérieux joins Novartis, others in $21m ImaginAb Series B round

news_biotech_lrg Novartis Ventures has taken part in a $21m syndicated Series B round for clinical-stage biotech business ImaginAb.

8 May 2014

NEA joins Aisling, OrbiMed to back cancer treatment business Loxo with $24m

life science test tube_sq Venture capital major New Enterprise Associates has led a $24m Series B financing round for cancer-focused biopharmaceutical business Loxo Oncology.

28 February 2014

Water-powered anti-cancer business NxThera raises $20m Series C

Venture capital-backed medical device company NxThera has pulled in more than its hoped-for $20m as it closed off a Series C financing round.

28 January 2014

Igenica’s venture backers all return for $14m Series C extension

virus2_sq Anti-cancer antibody developer Igenica has picked up $14m in Series C extension financing from all of its existing venture capital backers.

8 January 2014

AVG Ventures, Remeditex help cancer treatment company Bellicum to $34.4m Series B

AVG Ventures and Remeditex Ventures have increased their backing of Bellicum Pharmaceuticals to help it raise $34.4m for its Series B round.

Page 1 of 212

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014